This brand name is authorized in France, Italy, Tunisia, Turkey
The drug IPERTEN contains one active pharmaceutical ingredient (API):
|
1
Manidipine
UNII ZL507UZ6QL - MANIDIPINE HYDROCHLORIDE
|
|
Manidipine (INN) is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive. It is selective for vasculature and does not produce effects on the heart at clinically relevant dosages. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C08CA11 | Manidipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60456948, 65728537 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 029224045 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7133041 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699822010087 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
